Those with Ashkenazi Jewish ancestry have a one in 40 chance of carrying a BRCA1 or BRCA2 compared to a one in 250 chance for the general population.

In their next studies, they plan to study how the genetic program they uncovered is regulated over time. In addition, they could explore how this program interacts with other molecular processes to ...

BUFFALO, N.Y. – The University at Buffalo’s new Genetic Counseling Graduate Program has received accreditation from the Accreditation Council for Genetic Counseling (ACGC), the field’s national ...

For years, the promise of genetic testing has been clear: Identify people at elevated risk for cancer and intervene before the disease develops or when it's most treatable. Yet millions of Americans ...

A genetic counselor, though perhaps not as well-known as other healthcare professionals, plays a consequential role on a patient’s healthcare team – namely by helping a patient understand and adapt to ...

The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...

(WHTM) — There’s a local program called the Gene Health Project, and the idea is to learn any bad genetic news about yourself but learn it so early – that it’s actually good news. Crystal Ellwood’s ...

A breakthrough from the University of Cambridge is offering new hope for one of medicine’s most stubborn challenges: repairing damage to the brain and spinal cord. By growing miniature connected ...

Millions of genetic variants have been discovered over the last 25 years, but interpreting the clinical impact of the differences in a person's genome remains a major bottleneck in genomic medicine.

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ science, today announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly owned subsidiary ...